Cat Allergy – Pipeline Review, H1 2012

Published by: Global Markets Direct

Published: Jun. 28, 2012 - 35 Pages

Table of Contents

Introduction

Global Markets Direct Report Coverage

Cat Allergy Overview

Therapeutics Development

An Overview of Pipeline Products for Cat Allergy

Cat Allergy Therapeutics under Development by Companies

Mid Clinical Stage Products

Comparative Analysis

Discovery and Pre-Clinical Stage Products

Comparative Analysis

Cat Allergy Therapeutics – Products under Development by Companies

Companies Involved in Cat Allergy Therapeutics Development

ALK-Abello A/S

Circassia Holdings Ltd.

ImVisioN Therapeutics AG

Biomay AG

Cat Allergy – Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

ToleroMune Cat Allergy T Cell Vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

IVN201 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Cat Allergen Peptide Carrier Fusion Vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Cat Allergen RNA Vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Cat Allergen Hypoallergenic Vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Cat Allergy Therapeutics – Drug Profile Updates

Cat Allergy – Product Development Milestones

Featured News & Press Releases

Jun 13, 2011: Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction In Allergy Symptoms During 12-Month Follow-up

Feb 01, 2011: Circassia's ToleroMune T-cell Vaccine Achieves Significant Reduction In Allergy Symptoms In Key Phase II Clinical Study

Jan 19, 2010: Circassia Extends Its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite And Cat Allergies

Nov 20, 2009: Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune Cat Allergy Therapy

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products Under Development for Cat Allergy, H1 2012

Products under Development for Cat Allergy – Comparative Analysis, H1 2012

Number of Products under Development by Companies, H1 2012

Comparative Analysis by Mid Clinical Stage Development, H1 2012

Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2012

Products under Development by Companies, H1 2012

ALK-Abello A/S, H1 2012

Circassia Holdings Ltd., H1 2012

ImVisioN Therapeutics AG, H1 2012

Biomay AG, H1 2012

Assessment by Monotherapy Products, H1 2012

Assessment by Stage and Route of Administration, H1 2012

Assessment by Stage and Molecule Type, H1 2012

Cat Allergy Therapeutics – Drug Profile Updates

List of Figures

Number of Products under Development for Cat Allergy, H1 2012

Products under Development for Cat Allergy – Comparative Analysis, H1 2012

Products under Development by Companies, H1 2012

Mid Clinical Stage Products, H1 2012

Discovery and Pre-Clinical Stage Products, H1 2012

Assessment by Monotherapy Products, H1 2012

Assessment by Route of Administration, H1 2012

Assessment by Stage and Route of Administration, H1 2012

Assessment by Molecule Type, H1 2012

Assessment by Stage and Molecule Type, H1 2012

Abstract

• A snapshot of the global therapeutic scenario for Cat Allergy.
• A review of the Cat Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Cat Allergy pipeline on the basis of route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

• Identify and understand important and diverse types of therapeutics under development for Cat Allergy.
• Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
• Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Cat Allergy pipeline depth and focus of Cat Allergy therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.